세계의 디지털 당뇨병 관리 시장 : 제품별(디바이스, 당뇨병 앱, 서비스, 소프트웨어 플랫폼), 디바이스 유형별(핸드헬드, 웨어러블), 최종사용자별(병원, 자가치료/재택의료) 예측(-2028년)

Digital Diabetes Management Market by Product (Device (CGM, Smart Glucometer, Insulin Patch Pump), Diabetes Apps, Service, Software & Platforms), Device Type (Handheld & Wearables), End User (Hospitals & Self/Home Healthcare) - Global Forecast to 2028

US $ 4,950 ￦ 6,991,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,650 ￦ 9,393,000

PDF (5-user License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,150 ￦ 11,511,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 이용 인원에 제한은 없으나, 국내에 있는 사업장만 해당되며, 해외 지점 등은 포함되지 않습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000 ￦ 14,125,000

PDF (Global License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. (100% 자회사는 동일 기업으로 간주됩니다.) 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계의 디지털 당뇨병 관리 시장 규모는 2023년 168억 달러에서 2028년 313억 달러에 달하고, 예측 기간 동안 13.3%의 CAGR을 나타낼 것으로 예상됩니다.

당뇨병 유병률 증가로 인해 더 나은 당뇨병 치료 솔루션의 개발 및 도입의 중요성이 커지고 있습니다. 또한, 기술 개발로 인해 적응성이 높은 솔루션을 도입할 수 있게 되었습니다. 기타 주요 성장 촉진요인으로는 기업용 클라우드 기반 솔루션의 보급과 커넥티드 디바이스 및 앱의 사용 증가를 들 수 있습니다. 그러나 예측 기간 동안 높은 기기 가격, 신흥국 시장에서의 낮은 보험 환급, 기존 표준형 당뇨병 관리 기기의 수용 확대 등이 시장 성장을 저해하는 요인으로 작용할 것으로 예상됩니다.

"제품별로는 스마트 혈당 측정기 부문이 가장 큰 점유율을 차지."

2022년 디지털 당뇨병 관리 기기 시장에서 스마트 혈당 측정기 부문은 25.2% 시장 점유율을 차지했습니다. 스마트 혈당 측정기 사용의 편리함과 저혈당 및 고혈당 당뇨병의 조기 발견에 대한 이점이 이 시장 성장의 주요 원인으로 작용했습니다. 이 외에도 블루투스 지원 혈당 측정기, 분석 기능을 갖춘 올인원 혈당 측정기, 휴대용 포켓용 혈당 측정기 등의 기술 발전도 이 시장 부문의 인기 상승을 견인하고 있습니다.

"웨어러블 기기 부문이 예측 기간 동안 가장 높은 CAGR로 성장할 것"

디지털 당뇨병 관리 시장을 기기 유형별로 살펴보면, 2022년 웨어러블 기술이 시장의 60.3%를 차지할 것으로 예상됩니다. 이 부문은 예측 기간 동안 13.2%의 가장 높은 CAGR로 성장할 것으로 예상됩니다. 웨어러블 시장은 기술 발전, 스마트 인슐린 펌프 및 인슐린 패치의 채택 증가, 웨어러블 관련 규제 승인 증가 등의 영향으로 확대되고 있습니다.

"2022년에는 자가치료/재택의료 부문이 가장 큰 점유율을 차지할 것"

최종 사용자별로는 자가 치료/재택치료 부문이 2022년 가장 큰 시장 점유율을 차지할 것으로 예상됩니다. 이는 주로 당뇨병 관리를 위한 디지털 플랫폼에 대한 인식이 높아짐에 따라 재택치료를 받아들이는 환자가 증가했기 때문입니다. 지속적인 인슐린 치료가 필요한 환자들에게 자가 투약은 가장 큰 도움이 됩니다. 장기 치료가 필요한 환자들에게 입원 치료는 매우 비싸고 일상 생활로 돌아갈 수 없습니다는 문제도 있습니다.

"북미, 2021년 디지털 당뇨병 관리 시장에서 가장 큰 점유율을 차지할 것"

지역별로는 2022년 북미가 41.4%로 가장 큰 시장 점유율을 차지할 것으로 예상되며, 유럽이 29.0%로 그 뒤를 이었습니다. 커넥티드 당뇨병 관리 기기의 성장, 당뇨병 및 비만 관리 앱의 인기 상승, 기술적으로 진보된 솔루션에 대한 수요 증가, 지불자의 디지털 당뇨병 솔루션 수용 확대, 디지털 건강 증진에 대한 정부의 이니셔티브, 자가 당뇨병 관리에 대한 인식 증가 등이 북미가 디지털 당뇨병 관리 시장을 주도할 것으로 보입니다. 북미가 디지털 당뇨병 관리 시장을 주도하는 주요 요인으로 꼽히고 있습니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 프리미엄 인사이트

제5장 시장 개요

• 서론
• 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 기회
  • 과제
• 업계 동향
• 규제 분석
• 생태계 분석
• 밸류체인 분석
• Porter의 Five Forces 분석
• 특허 분석
• 가격 분석
• 공급망 분석
• 주요 컨퍼런스 및 이벤트(2023년-2024년)
• 주요 이해관계자와 구입 기준
• 기술 분석
• 상환 시나리오
• 무역 분석

제6장 디지털 당뇨병 관리 시장 : 제품 및 서비스별

• 서론
• 디바이스
  • 스마트 혈당 측정기
  • 연속 혈당 모니터링 기기(CGM)
  • 스마트 인슐린 펜
  • 스마트 인슐린 펌프/폐루프 시스템 및 스마트 인슐린 패치
• 디지털 당뇨병 관리 앱
  • 당뇨병 및 혈당 추적 앱
  • 체중 및 식사 관리 앱
• 데이터 관리 소프트웨어 및 플랫폼
• 서비스

제7장 디지털 당뇨병 관리 시장 : 유형별

• 서론
• 웨어러블 디바이스
• 핸드헬드 디바이스

제8장 디지털 당뇨병 관리 시장 : 최종사용자별

• 서론
• 자가치료/재택치료
• 병원 및 당뇨병 전문 클리닉
• 학술연구기관

제9장 디지털 당뇨병 관리 시장 : 지역별

• 서론
• 북미
  • 미국
  • 캐나다
• 유럽
  • 독일
  • 영국
  • 프랑스
  • 이탈리아
  • 스페인
  • 기타 유럽
• 아시아태평양
  • 중국
  • 일본
  • 인도
  • 호주
  • 한국
  • 기타 아시아태평양
• 라틴아메리카
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
• 중동 및 아프리카

제10장 경쟁 구도

• 개요
• 주요 기업의 전략/유력 기업
• 디지털 당뇨병 관리 시장 : 주요 기업의 매출 점유율 분석
• 시장 점유율 분석
• 기업 평가 매트릭스
• 스타트업/중소기업 평가 매트릭스(2022년)
• 경쟁 벤치마킹
• 경쟁 시나리오

제11장 기업 개요

• 주요 기업
  • MEDTRONIC
  • F. HOFFMANN-LA ROCHE
  • DEXCOM, INC.
  • ASCENSIA DIABETES CARE HOLDINGS AG
  • ABBOTT LABORATORIES
  • B. BRAUN MELSUNGEN AG
  • TIDEPOOL
  • GLOOKO, INC.
  • LIFESCAN, INC.
  • AGAMATRIX
  • TANDEM DIABETES CARE, INC.
  • INSULET CORPORATION
  • DARIOHEALTH CORPORATION
  • ONE DROP
  • YPSOMED HOLDING AG
• 기타 기업
  • ARKRAY
  • DOTTLI
  • ACON LABORATORIES, INC.
  • CARE INNOVATIONS, LLC
  • HEALTH2SYNC
  • EMPERRA GMBH E-HEALTH TECHNOLOGIES
  • AZUMIO
  • DECIDE CLINICAL SOFTWARE GMBH
  • PENDIQ GMBH
  • BEATO

제12장 부록

LSH

영문 목차

영문목차

The global digital diabetes management market is projected to reach USD 31.3 Billion by 2028 from an estimated USD 16.8 Billion in 2023, at a CAGR of 13.3% during the forecast period. The significance of developing and implementing better diabetes care solutions has increased due to the rising prevalence of diabetes. Additionally, technological development has made it feasible for the market to introduce highly adaptable solutions. Among the other key drivers of market growth are the rising adoption of cloud-based enterprise solutions and the rising use of connected devices and apps. But during the forecast period, factors like high device costs, a lack of reimbursement in developing countries, and a higher acceptance of standard and traditional diabetes management devices are anticipated to hinder the market growth.

"Smart glucose meters segment accounted for the largest share in the Digital Diabetes Management market."

The devices segment is sub-segmented into smart insulin pens, smart insulin pumps/closed-loop systems, smart insulin patches, smart insulin pens, and CGM systems. In 2022, the market for digital diabetes management devices was dominated by the smart glucose meter segment, which held a 25.2% market share. The convenience for using smart glucose meters and their advantages in the early detection of hypo- and hyperglycemic diabetes are primarily responsible for the growth of this market. Other factors driving the growing popularity of this market segment include technological advancements like Bluetooth-enabled glucometers, all-in-one glucometers with analysis capabilities, and portable, pocket-size glucometers.

"Wearable devices segment to grow at the highest CAGR during the forecast period."

Both handheld and wearable devices are the sub-segment of the device types that are taken into account in the digital diabetes management device market. In 2022, wearable technology accounted for 60.3% of the market for digital diabetes management devices. During the forecast period, this segment is anticipated to grow at the highest CAGR of 13.2%. The market for wearables is growing as a result of technological advancements, an increase in the adoption of smart insulin pumps and insulin patches, and an increase in the number of regulatory approvals for wearables.

"The Self/home healthcare segment accounted for the largest share of Digital Diabetes Management market in 2022"

In 2022, the self-/home healthcare segment held the largest market share for digital diabetes management. This is primarily attributed to the rising patient acceptance of home care as a result of growing awareness of digital platforms for managing diabetes. Patients who require continuous insulin therapy benefit most from self-administration. Inpatient treatment is very expensive for patients who require long-term therapy, and it also keeps them from going back to their daily routines.

"North America accounted for the largest share of the Digital Diabetes Management market in 2021"

North America held the largest market share in 2022 with a share of 41.4%, followed by Europe with a share of 29.0%. The growth of connected diabetes management devices, the rising popularity of diabetes and obesity management apps, the rising demand for technologically advanced solutions, the growing acceptance of digital diabetes solutions by payers, government initiatives to promote digital health, and increasing awareness of self-diabetes management in the region are the main factors driving North America to dominate the digital diabetes management market.

A breakdown of the primary participants (supply-side) for the Digital Diabetes Management market referred to for this report is provided below:

• By Company Type: Tier 1-46%, Tier 2-33%, and Tier 3-21%
• By Designation: C-level-43%, Director Level-35%, and Others-22%
• By Region: North America-34%, Europe-26%, Asia Pacific-19%, Latin America- 11%, and Middle East and Africa- 10%

The prominent players operating in the global digital diabetes management market are Medtronic (Ireland), B. Braun Melsungen AG (Germany), Dexcom, Inc. (US), Abbott Laboratories (US), F. Hoffmann-La Roche (Switzerland), Insulet Corporation (US), Tandem Diabetes Care (US), Dottli (Finland), Ypsomed Holding AG (Switzerland), ARKRAY (Japan), Ascensia Diabetes Care Holdings AG (Switzerland), Health2Sync (Taiwan), Emperra GmbH E-Health Technologies (Germany), ACON Laboratories, Inc. (US), Care Innovations, LLC (US), Azumio (US), LifeScan, Inc. (US), Tidepool (US), AgaMatrix (US), Glooko, Inc. (US), DarioHealth Corporation (Israel), One Drop (US), Decide Clinical Software GmbH (Austria), Pendiq GmbH (Germany), and BeatO (India).

Research Coverage:

The market study covers the digital diabetes management market across various segments. It aims at estimating the market size and the growth potential of this market across different segments by product & service, by device type, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall digital diabetes management market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report provides insights on the following pointers:

• Analysis of key drivers (Increasing Prevalence Of Diabetes, Technological Advancements and Growing Adoption Of Cloud-Based Enterprise Solutions For Diabetes Management), restraints (High Cost Of Devices And Lack Of Reimbursement In Developing Countries and Higher Acceptance Of Traditional Diabetes Management Devices), opportunities (Increasing Diabetes-Related Health Expenditure In Emerging Economies), and challenges (Low Penetration In Developing Economies and Lack Of Data Security) influencing the growth of the digital diabetes management market
• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the global digital diabetes management market
• Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product or service launches in the global digital diabetes management market
• Market Development: Comprehensive information on the lucrative emerging regions by product & services, device types, end users, and region
• Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the global digital diabetes management market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, revenue analysis, and products of leading players in the global digital diabetes management market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
  • 1.2.1 PRODUCT AND SERVICES
  • 1.2.2 DEVICE TYPE
  • 1.2.3 END USER
  • 1.2.4 INCLUSIONS AND EXCLUSIONS
• 1.3 MARKET SCOPE
  • 1.3.1 MARKETS COVERED
  • 1.3.2 YEARS CONSIDERED
• 1.4 CURRENCY CONSIDERED
  • TABLE 1 STANDARD CURRENCY CONVERSION RATES
• 1.5 LIMITATIONS
• 1.6 STAKEHOLDERS
• 1.7 SUMMARY OF CHANGES
  • 1.7.1 REFINEMENTS IN SEGMENTATION OF GLOBAL DIGITAL DIABETES MANAGEMENT MARKET
  • 1.7.2 UPDATED FINANCIAL INFORMATION/PRODUCT PORTFOLIOS OF PLAYERS
  • 1.7.3 UPDATED MARKET DEVELOPMENTS OF PROFILED PLAYERS
  • 1.7.4 ADDITION OF RECESSION IMPACT

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • FIGURE 1 RESEARCH DESIGN
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
  • FIGURE 2 PRIMARY SOURCES
    • 2.1.2.1 Key data from primary sources
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER AND REGION
• 2.2 MARKET SIZE ESTIMATION
  • FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2022)
  • FIGURE 6 MARKET SIZE ESTIMATION: COMPANY-WISE REVENUE SHARE ANALYSIS (2022)
  • FIGURE 7 SUPPLY-SIDE ANALYSIS: DIGITAL DIABETES MANAGEMENT MARKET (2022)
  • FIGURE 8 SUPPLY-SIDE ANALYSIS: SMART GLUCOSE METERS MARKET (2022)
  • FIGURE 9 SUPPLY-SIDE ANALYSIS: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET (2022)
  • FIGURE 10 SUPPLY-SIDE ANALYSIS: SMART INSULIN PENS MARKET (2022)
  • FIGURE 11 SUPPLY-SIDE ANALYSIS: SMART INSULIN PUMPS/CLOSED-LOOP SYSTEMS AND SMART INSULIN PATCHES MARKET (2022)
  • FIGURE 12 SUPPLY-SIDE ANALYSIS: DIGITAL DIABETES MANAGEMENT APPS MARKET (2022)
  • FIGURE 13 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES FOR DIGITAL DIABETES MANAGEMENT MARKET (2023-2028)
  • FIGURE 14 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS OF DIGITAL DIABETES MANAGEMENT MARKET
  • FIGURE 15 TOP-DOWN APPROACH: GLOBAL DIGITAL DIABETES MANAGEMENT MARKET
  • FIGURE 16 BOTTOM-UP APPROACH: GLOBAL DIGITAL DIABETES MANAGEMENT MARKET
  • FIGURE 17 GLOBAL DIGITAL DIABETES MANAGEMENT MARKET SIZING, BY DEVICE TYPE
• 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
  • FIGURE 18 DATA TRIANGULATION METHODOLOGY
• 2.4 MARKET SHARE ESTIMATION
• 2.5 STUDY ASSUMPTIONS
• 2.6 IMPACT OF RECESSION

3 EXECUTIVE SUMMARY

• FIGURE 19 DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION)
• FIGURE 20 DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2023 VS. 2028 (USD MILLION)
• FIGURE 21 DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
• FIGURE 22 DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
• FIGURE 23 DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
• FIGURE 24 DIGITAL DIABETES MANAGEMENT MARKET: GEOGRAPHICAL SNAPSHOT

4 PREMIUM INSIGHTS

• 4.1 DIGITAL DIABETES MANAGEMENT MARKET OVERVIEW
  • FIGURE 25 INCREASING PREVALENCE OF DIABETES AND GROWING DEMAND FOR DIGITAL SOLUTIONS TO DRIVE MARKET GROWTH
• 4.2 ASIA PACIFIC: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE AND COUNTRY (2022)
  • FIGURE 26 DEVICES TO ACCOUNT FOR LARGEST SHARE OF ASIA PACIFIC MARKET
• 4.3 DIGITAL DIABETES MANAGEMENT MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES
  • FIGURE 27 US TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
• 4.4 REGIONAL MIX: DIGITAL DIABETES MANAGEMENT MARKET
  • FIGURE 28 NORTH AMERICAN MARKET TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
• 4.5 DIGITAL DIABETES MANAGEMENT MARKET: DEVELOPED VS. DEVELOPING ECONOMIES, 2023 VS. 2028 (USD MILLION)
  • FIGURE 29 DEVELOPED ECONOMIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • FIGURE 30 DIGITAL DIABETES MANAGEMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • 5.2.1 DRIVERS
    • 5.2.1.1 Increasing prevalence of diabetes
  • TABLE 2 TOP FIVE COUNTRIES WITH HIGHEST NUMBER OF DIABETICS (20-79 YEARS), 2021 VS. 2045
    • 5.2.1.2 Technological advancements
  • TABLE 3 PRODUCT LAUNCHES WITH NEW TECHNOLOGICAL ADVANCEMENTS
    • 5.2.1.3 Growing adoption of cloud-based enterprise solutions for diabetes management
    • 5.2.1.4 Advent of artificial intelligence in diabetes care devices
    • 5.2.1.5 Increasing penetration of digital platforms and adoption of mobile apps for diabetes management
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 High cost of devices and lack of reimbursement in developing countries
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Increasing diabetes-related health expenditure
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Low adoption in developing economies
    • 5.2.4.2 Data security
• 5.3 INDUSTRY TRENDS
  • 5.3.1 GROWING DEMAND FOR HYBRID CLOSED-LOOP SYSTEMS/ARTIFICIAL PANCREAS DEVICE SYSTEMS
  • TABLE 4 HYBRID CLOSED-LOOP SYSTEMS: LATEST EXAMPLES
  • 5.3.2 GROWING NUMBER OF COLLABORATIONS BETWEEN STAKEHOLDERS
  • TABLE 5 RECENT COLLABORATIONS IN DIGITAL DIABETES MANAGEMENT MARKET
  • 5.3.3 INCREASING DEMAND FOR FLASH GLUCOSE MONITORING (FGM) SYSTEMS
• 5.4 REGULATORY ANALYSIS
  • 5.4.1 REGULATORY LANDSCAPE
    • 5.4.1.1 North America
      • 5.4.1.1.1 US
  • TABLE 6 US: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • FIGURE 31 FDA 510(K) APPROVAL PROCESS
    • 5.4.1.1.2 Canada
  • TABLE 7 CANADA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
    • 5.4.1.2 Europe
  • FIGURE 32 CE APPROVAL PROCESS FOR DIGITAL DIABETES MANAGEMENT SOLUTIONS
    • 5.4.1.3 Asia Pacific
      • 5.4.1.3.1 Australia
      • 5.4.1.3.2 Japan
  • TABLE 8 CLASSIFICATION OF MEDICAL DEVICES AND REVIEWING BODY IN JAPAN
    • 5.4.1.3.3 China
  • TABLE 9 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
    • 5.4.1.3.4 India
    • 5.4.1.4 Latin America
  • 5.4.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 10 INDICATIVE LIST OF REGULATORY AUTHORITIES
• 5.5 ECOSYSTEM ANALYSIS
  • FIGURE 33 DIGITAL DIABETES MANAGEMENT MARKET: ECOSYSTEM ANALYSIS (2022)
• 5.6 VALUE CHAIN ANALYSIS
  • FIGURE 34 DIGITAL DIABETES MANAGEMENT DEVICES MARKET: VALUE CHAIN ANALYSIS (2022)
• 5.7 PORTER'S FIVE FORCES ANALYSIS
  • TABLE 11 DIGITAL DIABETES MANAGEMENT MARKET: PORTER'S FIVE FORCES ANALYSIS
  • 5.7.1 THREAT OF NEW ENTRANTS
  • 5.7.2 INTENSITY OF COMPETITIVE RIVALRY
  • 5.7.3 BARGAINING POWER OF BUYERS
  • 5.7.4 BARGAINING POWER OF SUPPLIERS
  • 5.7.5 THREAT OF SUBSTITUTES
• 5.8 PATENT ANALYSIS
  • 5.8.1 PATENT PUBLICATION TRENDS FOR DIGITAL DIABETES MANAGEMENT
  • FIGURE 35 PATENT PUBLICATION TRENDS (JANUARY 2014-MAY 2023)
  • 5.8.2 TOP APPLICANTS (COMPANIES) FOR DIGITAL DIABETES MANAGEMENT PATENTS
  • FIGURE 36 TOP APPLICANT COMPANIES FOR DIGITAL DIABETES MANAGEMENT PATENTS, 2014-2023
  • 5.8.3 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR DIGITAL DIABETES MANAGEMENT PATENTS
  • FIGURE 37 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR DIGITAL DIABETES MANAGEMENT PATENTS, 2014-2023
• 5.9 PRICING ANALYSIS
  • 5.9.1 KEY PLAYERS: AVERAGE SELLING PRICE, BY DEVICE
  • TABLE 12 AVERAGE SELLING PRICE, BY DEVICE, 2022
• 5.10 SUPPLY CHAIN ANALYSIS
  • FIGURE 38 DIGITAL DIABETES MANAGEMENT MARKET: STAKEHOLDERS IN SUPPLY CHAIN
• 5.11 KEY CONFERENCES AND EVENTS IN 2023-2024
  • TABLE 13 DIGITAL DIABETES MANAGEMENT MARKET: LIST OF CONFERENCES AND EVENTS
• 5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • FIGURE 39 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 APPLICATIONS
  • TABLE 14 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 APPLICATIONS (%)
  • 5.12.2 BUYING CRITERIA
  • FIGURE 40 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS
  • TABLE 15 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS
• 5.13 TECHNOLOGY ANALYSIS
• 5.14 REIMBURSEMENT SCENARIO
  • TABLE 16 DIGITAL DIABETES MANAGEMENT PRODUCTS: GLOBAL COVERAGE AND REIMBURSEMENT
• 5.15 TRADE ANALYSIS
  • TABLE 17 TOP EXPORTERS OF DIGITAL DIABETES MANAGEMENT DEVICES, BY COUNTRY (2022)
  • TABLE 18 TOP IMPORTERS OF DIGITAL DIABETES MANAGEMENT DEVICES, BY COUNTRY (2022)

6 DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE

• 6.1 INTRODUCTION
  • TABLE 19 DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
• 6.2 DEVICES
  • TABLE 20 DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021-2028 (USD MILLION)
  • TABLE 21 DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 22 DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021-2028 (THOUSAND UNITS)
  • 6.2.1 SMART GLUCOSE METERS
    • 6.2.1.1 Reducing prices and technological innovations to drive growth
  • TABLE 23 KEY SMART GLUCOSE METERS OFFERED BY MARKET PLAYERS
  • TABLE 24 SMART GLUCOSE METERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 25 SMART GLUCOSE METERS MARKET, BY REGION, 2021-2028 (THOUSAND UNITS)
  • 6.2.2 CONTINUOUS GLUCOSE MONITORING SYSTEMS
    • 6.2.2.1 CGM segment to grow at highest CAGR during forecast period
  • TABLE 26 KEY CGM SYSTEMS OFFERED BY MARKET PLAYERS
  • TABLE 27 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 28 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2021-2028 (THOUSAND UNITS)
  • 6.2.3 SMART INSULIN PENS
    • 6.2.3.1 Increasing demand for personalized/patient-centric devices without risk of needle-stick injuries to drive growth
  • TABLE 29 KEY SMART INSULIN PENS OFFERED BY MARKET PLAYERS
  • TABLE 30 SMART INSULIN PENS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 31 SMART INSULIN PENS MARKET, BY REGION, 2021-2028 (THOUSAND UNITS)
  • 6.2.4 SMART INSULIN PUMPS/CLOSED-LOOP SYSTEMS AND SMART INSULIN PATCHES
    • 6.2.4.1 Benefits of smart insulin pumps and closed-loop systems to drive growth
  • TABLE 32 KEY SMART INSULIN PUMPS/CLOSED-LOOP SYSTEMS AND SMART INSULIN PATCHES OFFERED BY MARKET PLAYERS
  • TABLE 33 SMART INSULIN PUMPS/CLOSED-LOOP SYSTEMS AND SMART INSULIN PATCHES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 34 SMART INSULIN PUMPS/CLOSED-LOOP SYSTEMS AND SMART INSULIN PATCHES MARKET, BY REGION, 2021-2028 (THOUSAND UNITS)
• 6.3 DIGITAL DIABETES MANAGEMENT APPS
  • TABLE 35 DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 36 DIGITAL DIABETES MANAGEMENT APPS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.3.1 DIABETES AND BLOOD GLUCOSE TRACKING APPS
    • 6.3.1.1 Growing adoption of connected devices to drive growth
  • TABLE 37 KEY DIABETES AND BLOOD GLUCOSE TRACKING APPS OFFERED BY MARKET PLAYERS
  • TABLE 38 DIABETES AND BLOOD GLUCOSE TRACKING APPS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.3.2 WEIGHT AND DIET MANAGEMENT APPS
    • 6.3.2.1 Growing obese population and increasing need to prevent diabetes to drive growth
  • TABLE 39 KEY WEIGHT AND DIET MANAGEMENT APPS OFFERED BY MARKET PLAYERS
  • TABLE 40 WEIGHT AND DIET MANAGEMENT APPS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
• 6.4 DATA MANAGEMENT SOFTWARE AND PLATFORMS
  • 6.4.1 GROWING DEMAND FOR DIABETES DATA MANAGEMENT TO DRIVE GROWTH
  • TABLE 41 KEY DATA MANAGEMENT SOFTWARE AND PLATFORMS OFFERED BY MARKET PLAYERS
  • TABLE 42 DATA MANAGEMENT SOFTWARE AND PLATFORMS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
• 6.5 SERVICES
  • 6.5.1 INCREASING ADOPTION OF REMOTE ONLINE COACHING SERVICES AMONG DIABETES PATIENTS TO DRIVE GROWTH
  • TABLE 43 KEY SERVICES OFFERED BY MARKET PLAYERS
  • TABLE 44 DIGITAL DIABETES MANAGEMENT SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)

7 DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE

• 7.1 INTRODUCTION
  • TABLE 45 DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
• 7.2 WEARABLE DEVICES
  • 7.2.1 WEARABLE DEVICES TO DOMINATE DIGITAL DIABETES MANAGEMENT DEVICES MARKET DURING FORECAST PERIOD
  • TABLE 46 WEARABLE DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
• 7.3 HANDHELD DEVICES
  • 7.3.1 INCREASING DEMAND FOR REMOTE MONITORING TO BOOST GROWTH
  • TABLE 47 HANDHELD DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)

8 DIGITAL DIABETES MANAGEMENT MARKET, BY END USER

• 8.1 INTRODUCTION
  • TABLE 48 DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021-2028 (USD MILLION)
• 8.2 SELF/HOME HEALTHCARE
  • 8.2.1 HIGH COST OF INPATIENT CARE TO FUEL PREFERENCE FOR SELF/HOME CARE
  • TABLE 49 DIGITAL DIABETES MANAGEMENT MARKET FOR SELF/HOME HEALTHCARE, BY COUNTRY, 2021-2028 (USD MILLION)
• 8.3 HOSPITALS AND SPECIALTY DIABETES CLINICS
  • 8.3.1 RISING DEMAND FOR POC TESTING IN HOSPITALS TO BOOST GROWTH
  • TABLE 50 DIGITAL DIABETES MANAGEMENT MARKET FOR HOSPITALS AND SPECIALTY DIABETES CLINICS, BY COUNTRY, 2021-2028 (USD MILLION)
• 8.4 ACADEMIC AND RESEARCH INSTITUTES
  • 8.4.1 PRODUCT INNOVATION FOR DIABETES MANAGEMENT TO DRIVE GROWTH
  • TABLE 51 DIGITAL DIABETES MANAGEMENT MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)

9 DIGITAL DIABETES MANAGEMENT MARKET, BY REGION

• 9.1 INTRODUCTION
  • FIGURE 41 DIGITAL DIABETES MANAGEMENT MARKET: GEOGRAPHIC SNAPSHOT
  • TABLE 52 DIGITAL DIABETES MANAGEMENT MARKET, BY REGION, 2021-2028 (USD MILLION)
• 9.2 NORTH AMERICA
  • 9.2.1 NORTH AMERICA: RECESSION IMPACT
  • FIGURE 42 NORTH AMERICA: DIGITAL DIABETES MANAGEMENT MARKET SNAPSHOT
  • TABLE 53 NORTH AMERICA: DIGITAL DIABETES MANAGEMENT MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 54 NORTH AMERICA: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 55 NORTH AMERICA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021-2028 (USD MILLION)
  • TABLE 56 NORTH AMERICA: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 57 NORTH AMERICA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 58 NORTH AMERICA: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.2.2 US
    • 9.2.2.1 Increasing diabetes prevalence and high penetration of digital platforms to boost market
  • TABLE 59 US: MACROECONOMIC INDICATORS
  • TABLE 60 US: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 61 US: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021-2028 (USD MILLION)
  • TABLE 62 US: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 63 US: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 64 US: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.2.3 CANADA
    • 9.2.3.1 Favorable reimbursement scenario to drive digital diabetes management adoption in Canada
  • TABLE 65 CANADA: MACROECONOMIC INDICATORS
  • TABLE 66 CANADA: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 67 CANADA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021-2028 (USD MILLION)
  • TABLE 68 CANADA: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 69 CANADA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 70 CANADA: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021-2028 (USD MILLION)
• 9.3 EUROPE
  • 9.3.1 EUROPE: RECESSION IMPACT
  • FIGURE 43 EUROPE: DIGITAL DIABETES MANAGEMENT MARKET SNAPSHOT
  • TABLE 71 EUROPE: DIGITAL DIABETES MANAGEMENT MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 72 EUROPE: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 73 EUROPE: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021-2028 (USD MILLION)
  • TABLE 74 EUROPE: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 75 EUROPE: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 76 EUROPE: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.3.2 GERMANY
    • 9.3.2.1 Germany to dominate European market over forecast period
  • TABLE 77 GERMANY: MACROECONOMIC INDICATORS
  • TABLE 78 GERMANY: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 79 GERMANY: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021-2028 (USD MILLION)
  • TABLE 80 GERMANY: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 81 GERMANY: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 82 GERMANY: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.3.3 UK
    • 9.3.3.1 Government initiatives to support market growth
  • TABLE 83 UK: MACROECONOMIC INDICATORS
  • TABLE 84 UK: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 85 UK: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021-2028 (USD MILLION)
  • TABLE 86 UK: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 87 UK: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 88 UK: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.3.4 FRANCE
    • 9.3.4.1 Affordability of healthcare to propel adoption of digital solutions
  • TABLE 89 FRANCE: MACROECONOMIC INDICATORS
  • TABLE 90 FRANCE: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 91 FRANCE: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021-2028 (USD MILLION)
  • TABLE 92 FRANCE: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 93 FRANCE: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 94 FRANCE: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.3.5 ITALY
    • 9.3.5.1 Rising diabetes prevalence to offer growth opportunities
  • TABLE 95 ITALY: MACROECONOMIC INDICATORS
  • TABLE 96 ITALY: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 97 ITALY: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021-2028 (USD MILLION)
  • TABLE 98 ITALY: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 99 ITALY: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 100 ITALY: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.3.6 SPAIN
    • 9.3.6.1 Growing healthcare budget and efforts to boost local manufacturing of medical products
  • TABLE 101 SPAIN: MACROECONOMIC INDICATORS
  • TABLE 102 SPAIN: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 103 SPAIN: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021-2028 (USD MILLION)
  • TABLE 104 SPAIN: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 105 SPAIN: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 106 SPAIN: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.3.7 REST OF EUROPE
  • TABLE 107 REST OF EUROPE: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 108 REST OF EUROPE: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021-2028 (USD MILLION)
  • TABLE 109 REST OF EUROPE: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 110 REST OF EUROPE: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 111 REST OF EUROPE: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021-2028 (USD MILLION)
• 9.4 ASIA PACIFIC
  • 9.4.1 ASIA PACIFIC: RECESSION IMPACT
  • FIGURE 44 ASIA PACIFIC: DIGITAL DIABETES MANAGEMENT MARKET SNAPSHOT
  • TABLE 112 ASIA PACIFIC: DIGITAL DIABETES MANAGEMENT MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 113 ASIA PACIFIC: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 114 ASIA PACIFIC: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021-2028 (USD MILLION)
  • TABLE 115 ASIA PACIFIC: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 116 ASIA PACIFIC: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 117 ASIA PACIFIC: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.4.2 CHINA
    • 9.4.2.1 China to hold largest share of APAC market
  • TABLE 118 CHINA: MACROECONOMIC INDICATORS
  • TABLE 119 CHINA: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 120 CHINA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021-2028 (USD MILLION)
  • TABLE 121 CHINA: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 122 CHINA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 123 CHINA: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.4.3 JAPAN
    • 9.4.3.1 High acceptance of digital solutions for diabetes management to boost growth
  • TABLE 124 JAPAN: MACROECONOMIC INDICATORS
  • TABLE 125 JAPAN: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 126 JAPAN: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021-2028 (USD MILLION)
  • TABLE 127 JAPAN: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 128 JAPAN: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 129 JAPAN: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.4.4 INDIA
    • 9.4.4.1 Rising diabetes prevalence and focus on cost curtailment to favor adoption
  • TABLE 130 INDIA: MACROECONOMIC INDICATORS
  • TABLE 131 INDIA: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 132 INDIA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021-2028 (USD MILLION)
  • TABLE 133 INDIA: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 134 INDIA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 135 INDIA: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.4.5 AUSTRALIA
    • 9.4.5.1 Initiatives to help treat or manage diabetes-related problems to drive market growth
  • TABLE 136 AUSTRALIA: MACROECONOMIC INDICATORS
  • TABLE 137 AUSTRALIA: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 138 AUSTRALIA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021-2028 (USD MILLION)
  • TABLE 139 AUSTRALIA: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 140 AUSTRALIA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 141 AUSTRALIA: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.4.6 SOUTH KOREA
    • 9.4.6.1 Government initiatives for diabetes management to drive growth
  • TABLE 142 SOUTH KOREA: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 143 SOUTH KOREA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021-2028 (USD MILLION)
  • TABLE 144 SOUTH KOREA: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 145 SOUTH KOREA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 146 SOUTH KOREA: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.4.7 REST OF ASIA PACIFIC
  • TABLE 147 REST OF ASIA PACIFIC: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 148 REST OF ASIA PACIFIC: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021-2028 (USD MILLION)
  • TABLE 149 REST OF ASIA PACIFIC: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 150 REST OF ASIA PACIFIC: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 151 REST OF ASIA PACIFIC: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021-2028 (USD MILLION)
• 9.5 LATIN AMERICA
  • 9.5.1 LATIN AMERICA: RECESSION IMPACT
  • TABLE 152 LATIN AMERICA: DIGITAL DIABETES MANAGEMENT MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 153 LATIN AMERICA: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 154 LATIN AMERICA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021-2028 (USD MILLION)
  • TABLE 155 LATIN AMERICA: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 156 LATIN AMERICA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 157 LATIN AMERICA: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.5.2 BRAZIL
    • 9.5.2.1 High private healthcare expenditure and increasing geriatric population to drive market
  • TABLE 158 BRAZIL: MACROECONOMIC INDICATORS
  • TABLE 159 BRAZIL: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 160 BRAZIL: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021-2028 (USD MILLION)
  • TABLE 161 BRAZIL: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 162 BRAZIL: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 163 BRAZIL: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.5.3 MEXICO
    • 9.5.3.1 Growing obesity rate in Mexico to drive market
  • TABLE 164 MEXICO: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 165 MEXICO: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021-2028 (USD MILLION)
  • TABLE 166 MEXICO: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 167 MEXICO: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 168 MEXICO: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.5.4 REST OF LATIN AMERICA
  • TABLE 169 REST OF LATIN AMERICA: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 170 REST OF LATIN AMERICA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021-2028 (USD MILLION)
  • TABLE 171 REST OF LATIN AMERICA: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 172 REST OF LATIN AMERICA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 173 REST OF LATIN AMERICA: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021-2028 (USD MILLION)
• 9.6 MIDDLE EAST & AFRICA
  • 9.6.1 SLOW DIGITIZATION OF HEALTH SYSTEMS IN AFRICAN COUNTRIES TO AFFECT GROWTH
  • 9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
  • TABLE 174 AFRICA: MACROECONOMIC INDICATORS
  • TABLE 175 MIDDLE EAST & AFRICA: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 176 MIDDLE EAST & AFRICA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2021-2028 (USD MILLION)
  • TABLE 177 MIDDLE EAST & AFRICA: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 178 MIDDLE EAST & AFRICA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 179 MIDDLE EAST & AFRICA: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2021-2028 (USD MILLION)

10 COMPETITIVE LANDSCAPE

• 10.1 OVERVIEW
• 10.2 STRATEGIES OF KEY PLAYERS/RIGHT TO WIN
  • FIGURE 45 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN DIGITAL DIABETES MANAGEMENT MARKET
• 10.3 REVENUE SHARE ANALYSIS OF KEY PLAYERS IN DIGITAL DIABETES MANAGEMENT MARKET
  • FIGURE 46 REVENUE SHARE ANALYSIS OF KEY PLAYERS OPERATING IN DIGITAL DIABETES MANAGEMENT MARKET (2018-2022)
• 10.4 MARKET SHARE ANALYSIS
  • FIGURE 47 MARKET SHARE ANALYSIS: SMART GLUCOSE METERS MARKET (2022)
  • FIGURE 48 MARKET SHARE ANALYSIS: CONTINUOUS GLUCOSE MONITORING DEVICES MARKET (2022)
  • FIGURE 49 MARKET SHARE ANALYSIS: INSULIN PUMPS MARKET (2022)
  • FIGURE 50 MARKET SHARE ANALYSIS: SMART INSULIN PENS MARKET (2022)
  • FIGURE 51 MARKET SHARE ANALYSIS: DIABETES APPS MARKET (2022)
• 10.5 COMPANY EVALUATION MATRIX
  • FIGURE 52 DIGITAL DIABETES MANAGEMENT MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022
  • 10.5.1 STARS
  • 10.5.2 EMERGING LEADERS
  • 10.5.3 PERVASIVE PLAYERS
  • 10.5.4 PARTICIPANTS
• 10.6 EVALUATION MATRIX FOR START-UP/SME PLAYERS (2022)
  • FIGURE 53 DIGITAL DIABETES MANAGEMENT MARKET: COMPANY EVALUATION MATRIX FOR START-UP/SME PLAYERS, 2022
  • 10.6.1 PROGRESSIVE COMPANIES
  • 10.6.2 DYNAMIC COMPANIES
  • 10.6.3 STARTING BLOCKS
  • 10.6.4 RESPONSIVE COMPANIES
• 10.7 COMPETITIVE BENCHMARKING
  • 10.7.1 OVERALL FOOTPRINT OF COMPANIES
  • TABLE 180 OVERALL FOOTPRINT OF COMPANIES
  • TABLE 181 COMPANY FOOTPRINT: BY PRODUCT & SERVICE
  • TABLE 182 COMPANY FOOTPRINT: BY DEVICE TYPE
  • TABLE 183 COMPANY FOOTPRINT: BY END USER
  • TABLE 184 COMPANY FOOTPRINT: BY REGION
• 10.8 COMPETITIVE SCENARIO
  • 10.8.1 PRODUCT LAUNCHES
  • TABLE 185 PRODUCT LAUNCHES
  • 10.8.2 DEALS
  • TABLE 186 DEALS

11 COMPANY PROFILES

• 11.1 KEY PLAYERS
• (Business overview, Products & services offered, Recent developments, MnM view, Key strengths, Strategic choices, and Weaknesses and competitive threats)**
• 11.1.1 MEDTRONIC
• TABLE 187 MEDTRONIC: BUSINESS OVERVIEW
• FIGURE 54 MEDTRONIC: COMPANY SNAPSHOT (2022)
• 11.1.2 F. HOFFMANN-LA ROCHE
• TABLE 188 F. HOFFMANN-LA ROCHE: BUSINESS OVERVIEW
• FIGURE 55 F. HOFFMANN-LA ROCHE: COMPANY SNAPSHOT (2022)
• 11.1.3 DEXCOM, INC.
• TABLE 189 DEXCOM, INC.: BUSINESS OVERVIEW
• FIGURE 56 DEXCOM, INC.: COMPANY SNAPSHOT (2022)
• 11.1.4 ASCENSIA DIABETES CARE HOLDINGS AG
• TABLE 190 ASCENSIA DIABETES CARE HOLDINGS AG: BUSINESS OVERVIEW
• 11.1.5 ABBOTT LABORATORIES
• TABLE 191 ABBOTT LABORATORIES: BUSINESS OVERVIEW
• FIGURE 57 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2022)
• 11.1.6 B. BRAUN MELSUNGEN AG
• TABLE 192 B. BRAUN MELSUNGEN AG: BUSINESS OVERVIEW
• FIGURE 58 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2022)
• 11.1.7 TIDEPOOL
• TABLE 193 TIDEPOOL: BUSINESS OVERVIEW
• 11.1.8 GLOOKO, INC.
• TABLE 194 GLOOKO, INC.: BUSINESS OVERVIEW
• 11.1.9 LIFESCAN, INC.
• TABLE 195 LIFESCAN, INC.: BUSINESS OVERVIEW
• 11.1.10 AGAMATRIX
• TABLE 196 AGAMATRIX: BUSINESS OVERVIEW
• 11.1.11 TANDEM DIABETES CARE, INC.
• TABLE 197 TANDEM DIABETES CARE, INC.: BUSINESS OVERVIEW
• FIGURE 59 TANDEM DIABETES CARE, INC.: COMPANY SNAPSHOT (2022)
• 11.1.12 INSULET CORPORATION
• TABLE 198 INSULET CORPORATION: BUSINESS OVERVIEW
• FIGURE 60 INSULET CORPORATION: COMPANY SNAPSHOT (2022)
• 11.1.13 DARIOHEALTH CORPORATION
• TABLE 199 DARIOHEALTH CORPORATION: BUSINESS OVERVIEW
• FIGURE 61 DARIOHEALTH CORPORATION: COMPANY SNAPSHOT (2022)
• 11.1.14 ONE DROP
• TABLE 200 ONE DROP: BUSINESS OVERVIEW
• 11.1.15 YPSOMED HOLDING AG
• TABLE 201 YPSOMED HOLDING AG: BUSINESS OVERVIEW
• FIGURE 62 YPSOMED HOLDING AG: COMPANY SNAPSHOT (2022)
• 11.2 OTHER PLAYERS
  • 11.2.1 ARKRAY
  • 11.2.2 DOTTLI
  • 11.2.3 ACON LABORATORIES, INC.
  • 11.2.4 CARE INNOVATIONS, LLC
  • 11.2.5 HEALTH2SYNC
  • 11.2.6 EMPERRA GMBH E-HEALTH TECHNOLOGIES
  • 11.2.7 AZUMIO
  • 11.2.8 DECIDE CLINICAL SOFTWARE GMBH
  • 11.2.9 PENDIQ GMBH
  • 11.2.10 BEATO
• *Details on Business overview, Products & services offered, Recent developments, MnM view, Key strengths, Strategic choices, and Weaknesses and competitive threats might not be captured in case of unlisted companies.

12 APPENDIX

• 12.1 DISCUSSION GUIDE
• 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 12.3 CUSTOMIZATION OPTIONS
• 12.4 RELATED REPORTS
• 12.5 AUTHOR DETAILS

관련자료